NRSN - NeuroSense Therapeutics Ltd Uzoq muddatli majburiyatlarning kapitalga nisbati
Alon Ben-Nun jamoasi ayni paytda aksiyadorlar ishonchini saqlab qolgan holda klinik sinovlarni optimallashtirmoqda. NeuroSense Therapeutics (NRSN) ALS va PLP bilan kurashish uchun patent himoyasidagi sinergik platformalarga tayanadi. Uning dori vositalarining global miqyosda kengayish salohiyati yuqori daromadli ekanligini ta'minlaydi. Uzoq muddatli qarzning kapitalga nisbati moliyaviy barqarorlikni namoyish etadi, bunda 0.00 qiymati kreditga bog'liqlik holatini aks ettiradi.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_NRSN_-_NeuroSense-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "NRSN: NeuroSense Therapeutics, Ltd. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
NeuroSense Therapeutics Ltd (NRSN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati NeuroSense Therapeutics|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi NeuroSense Therapeutics, Ltd.|NRSN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar NeuroSense Therapeutics Ltd.|NRSN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari NeuroSense Therapeutics
Kompaniyaning jamlanma tahliliyoti:NRSN neurosense-tx.com
Investorlar NeuroSense Therapeutics (NRSN) kompaniyasini markaziy nerv tizimi terapiyasi sohasidagi ustunligi nuqtai nazaridan baholamoqdalar. Ushbu koeffitsient moliyaviy barqarorlikni tahlil qilish uchun bir yildan ortiq muddatli majburiyatlarni kapitalga nisbatan taqqoslaydi. Uzoq muddatli qarzlarning kapitalga nisbati tarixi kredit yuki va aktivlarni himoya qilish o'rtasidagi muvozanatni aks ettiradi. Ushbu ko'rsatkichning pasayishi noyob PrimeC kapsulalarini ishlab chiqish davrida xatarlarni minimallashtiradi. Talabning past elastikligi kompaniyaga o'z qarzlarini samarali boshqarish imkonini beradi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|CPRX (Catalyst Corp) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics (DNLI)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi harmonybiosciences.com|Biohaven - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Amylyx Pharmaceuticals Inc AMLX|Uzoq muddatli qarzning o'z kapitaliga nisbati TRVI (Trevi Pharma)|Praxis Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Anavex Life Sciences (AVXL)|CBLL: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati PRTA|ALEC (Alector) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ANNX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Omeros Corp.|Neurogene Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ACIU (acimmune.com)|VYGR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Neumora - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati SCLX (Scilex Holding Co.)|TVGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ACOG|Uzoq muddatli majburiyatlarning kapitalga nisbati cogrx.com|IKT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Cassava Sciences Inc (SAVA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc.|Uzoq muddatli kreditlarning kapitalga nisbati coyatherapeutics.com (COYA)|Uzoq muddatli qarzning kapitalga nisbati Vistagen|Uzoq muddatli qarzning kapitalga koeffitsiyenti Ovid Therapeutics Inc OVID|ABOS (Acumen Pharmaceuticals, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|CRVO: Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati alteritytherapeutics.com ATHE|Clene (CLNN) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati JUNS|RLMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Annovis Bio Inc (ANVS)|GRCE: Uzoq muddatli qarzning kapitalga nisbati|AIFF - Uzoq muddatli majburiyatlarning kapitalga nisbati|ANEW Medical, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|revivapharma.com (RVPH) - Uzoq muddatli qarzning kapitalga nisbati|MTVA - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeurAxis Inc. (NRXS) - Uzoq muddatli kreditlarning kapitalga nisbati|HSDT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Passage Bio Corp|Uzoq muddatli qarzning kapitalga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati NERV (minervaneurosciences.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati ATHA|Addex Therapeutics Ltd. - Uzoq muddatli qarzdorlikning kapitalga nisbati|Alzamend (ALZN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati protagenic.com PTIX|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CRGT: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi CARA (Cara Therapeutics Inc)|CHRO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Eliem Therapeutics, Inc. ELYM|ITCI (Intra-Cellular) - Uzoq muddatli qarzning kapitalga nisbati|Longboard Pharmaceuticals Inc (LBPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati|MRNS: Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning kapitalga nisbati|NRBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SAGE|Synaptogenix - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TRVN (Trevena Inc.)|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Anew Medical Inc. WENA|CERE (Cerevel Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati